Skip to Content
Merck
  • Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

British journal of pharmacology (2009-02-18)
P van Ruitenbeek, A Vermeeren, F T Y Smulders, A Sambeth, W J Riedel
ABSTRACT

Centrally active antihistamines impair cognitive performance, particularly sensorimotor performance. The aim of the present study was to further elucidate the scarcely studied subprocesses involved in sensorimotor performance, which may be affected by H1 receptor blockade. Better knowledge about the cognitive deficits associated with histamine dysfunction can contribute to better treatment of clinical disorders in which histamine hypofunction may be a contributing factor, such as in schizophrenia. Interactions of dexchlorpheniramine with specific task manipulations in a choice reaction time task were studied. Task demands were increased at the level of sensory subprocesses by decreasing stimulus quality, and at the level of motor subprocesses by increasing response complexity. A total of 18 healthy volunteers (9 female) aged between 18 and 45 years participated in a three-way, double-blind, crossover design. Treatments were single oral doses of 4 mg dexchlorpheniramine, 1 mg lorazepam and placebo. Behavioural effects were assessed by measuring reaction times and effects on brain activity by event-related potentials. Dexchlorpheniramine significantly slowed reaction times, but did not significantly interact with task manipulations. However, it did significantly interact with stimulus quality, as measured by event-related potentials. Lorazepam slowed reaction times and interacted with perceptual manipulations, as shown by effects on reaction times. The results confirm that the histamine system is involved in sensory information processing and show that H1 blockade does not affect motoric information processing. Histamine hypofunction in clinical disorders may cause impaired sensory processing, which may be a drug target.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
S-(+)-Chlorpheniramine maleate salt
Supelco
Chlorpheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
Dexchlorpheniramine maleate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
(±)-Chlorpheniramine maleate salt, ≥99% (perchloric acid titration)
Supelco
Chlorpheniramine maleate salt solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Chlorphenamine maleate, European Pharmacopoeia (EP) Reference Standard